Revenue: $1,217,227,000; YoY +4.71%; QoQ +3.62%.
Gross Profit: $944,062,000; Gross Margin 77.56%; YoY +7.59%; QoQ +5.33%.
Operating Income: $321,735,000; Operating Margin 26.43%; YoY +58.98%; QoQ +33.17%.
Net Income: $358,592,000; Net Margin 29.46%; YoY +63.73%; QoQ +40.84%.
EPS (Diluted): $1.16; EPS (Basic): $1.19; YoY +67.61%; QoQ +42.51%.
EBITDA: $321,735,000; EBITDA Margin ~26.4%.
R&D Expenses: $206,447,000; SG&A Expenses: $76,885,000; Selling & Marketing: $338,995,000; Total Operating Expenses: $622,327,000; COGS: $273,165,000.
Balance Sheet Highlights: Cash & cash equivalents $1,198,576,000; Short-term investments $6,580,073,000; Total cash and short-term investments $7,778,649,000.
Total Assets: $11,044,063,000; Total Liabilities: $2,093,986,000; Total Stockholders’ Equity: $8,950,077,000.
Deferred Revenue (Current): $1,465,044,000; Long-term debt: $32,015,000; Net Debt: -$1,166,561,000 (net cash position).
Capital Allocation: Common stock repurchased $36,058,000 during the period.Weighted average shares outstanding: 301,779,000 (basic) / 308,224,000 (diluted).